COVID vaccination of children age 5-11 cut Omicron hospitalizations by 68%

Study finds mRNA boosters were highly effective against symptomatic delta infection, but they were less effective against symptomatic omicron infection

Multistate Outbreak of Melioidosis Associated with Imported Aromatherapy Spray

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons | NEJM

BNT162b2 Vaccine Booster and Mortality Due to Covid-19

Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease

Moderna COVID-19 vaccine is slightly more effective than the Pfizer inoculation.

Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections

Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Vaccine efficacy for Pfizer shows a greater decline in men and those with immunosuppression over a period of 6 months

Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention | NEJM

Call for Emergency Action to Limit Global Temperature Increases, Restore Biodiversity, and Protect Health | NEJM

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM

The Moderna COVID-19 vaccine is safe and efficacious in adolescents according to a new study based on Phase 2/3 data published in The New England Journal of Medicine

Dietary salt substitute reduces heart disease deaths and all-cause mortality - a cluster-randomized trial of subjects aged over 60 with high blood pressure, or a history of stroke

Researchers have successfully developed a 'speech neuroprosthesis' that has enabled a man with severe paralysis to communicate in sentences, translating signals from his brain to the vocal tract directly into words that appear as text on a screen.

A blood marker predicts who gets ‘breakthrough’ COVID | NEJM

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM

Researchers develop technology to decode speech from cerebral cortical activity

A new era for medicine: successful, first of its kind, CRISPR-Cas9 gene editing in people with ATTR amyloidosis

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 | NEJM

Trial of Psilocybin versus Escitalopram for Depression | NEJM

Trial of Psilocybin versus Escitalopram for Depression

Preliminary study findings show that mRNA COVID-19 vaccines are safe for pregnant persons

Astra Zeneca vaccine does not protect against mild-to-moderate Covid-19 due to the South African variant.

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 | NEJM

The Pfizer COVID-19 vaccine has proven 94 percent effective in a study involving 1.2 million people in Israel, the first peer-reviewed real world research confirming the power of mass immunization campaigns to bring the pandemic to a close.

Single Dose of Moderna, Pfizer COVID-19 Vaccine Nearly as Effective as Two Doses.

The use of naltrexone plus bupropion to treat methamphetamine use disorder

More →